| Cas No.: | 1193314-23-6 |
| Synonyms: | NITD609, CHEMBL1082723, UNII-Z7Q4FWA04P, SureCN1306342, Z7Q4FWA04P, NITD-609 |
| SMILES: | FC1=C(Cl)C=C(NC2=C3C[C@H](C)N[C@@]2(C4=C(C=CC(Cl)=C4)N5)C5=O)C3=C1 |
| Formula: | C19H14Cl2FN3O |
| M.Wt: | 390.2383 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | NITD 609 is a novel and potent drug candidate for the treatment of uncomplicated malarial. NITD 609 improves potency > 80-fold against NF54 and K1 strains (IC50 < 1 nM), low metabolic clearance and no CYP450 liability, oral exposure improved 7 times and excellent bioavailability.. For the detailed information of NITD 609, the solubility of NITD 609 in water, the solubility of NITD 609 in DMSO, the solubility of NITD 609 in PBS buffer, the animal experiment (test) of NITD 609, the cell expriment (test) of NITD 609, the in vivo, in vitro and clinical trial test of NITD 609, the EC50, IC50,and affinity,of NITD 609, Please contact DC Chemicals. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|